-
Je něco špatně v tomto záznamu ?
Inhibition of ATR kinase with the selective inhibitor VE-821 results in radiosensitization of cells of promyelocytic leukaemia (HL-60)
J. Vávrová, L. Zárybnická, E. Lukášová, M. Řezáčová, E. Novotná, Z. Sinkorová, A. Tichý, J. Pejchal, K. Durišová,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 2002-06-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2011-03-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2002-06-01 do Před 1 rokem
- MeSH
- akutní promyelocytární leukemie patologie MeSH
- apoptóza účinky léků MeSH
- ATM protein antagonisté a inhibitory MeSH
- HL-60 buňky MeSH
- inhibitory proteinkinas farmakologie MeSH
- kontrolní body fáze G2 buněčného cyklu účinky léků MeSH
- lidé MeSH
- morfoliny farmakologie MeSH
- oprava DNA účinky léků MeSH
- pyraziny farmakologie MeSH
- pyrony farmakologie MeSH
- sulfony farmakologie MeSH
- tolerance záření účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
We compared the effects of inhibitors of kinases ATM (KU55933) and ATR (VE-821) (incubated for 30 min before irradiation) on the radiosensitization of human promyelocyte leukaemia cells (HL-60), lacking functional protein p53. VE-821 reduces phosphorylation of check-point kinase 1 at serine 345, and KU55933 reduces phosphorylation of check-point kinase 2 on threonine 68 as assayed 4 h after irradiation by the dose of 6 Gy. Within 24 h after gamma-irradiation with a dose of 3 Gy, the cells accumulated in the G2 phase (67 %) and the number of cells in S phase decreased. KU55933 (10 μM) did not affect the accumulation of cells in G2 phase and did not affect the decrease in the number of cells in S phase after irradiation. VE-821 (2 and 10 μM) reduced the number of irradiated cells in the G2 phase to the level of non-irradiated cells and increased the number of irradiated cells in S phase, compared to irradiated cells not treated with inhibitors. In the 144 h interval after irradiation with 3 Gy, there was a considerable induction of apoptosis in the VE-821 group (10 μM). The repair of the radiation damage, as observed 72 h after irradiation, was more rapid in the group exposed solely to irradiation and in the group treated with KU55933 (80 and 77 % of cells, respectively, were free of DSBs), whereas in the group incubated with 10 μM VE-821, there were only 61 % of cells free of DSBs. The inhibition of kinase ATR with its specific inhibitor VE-821 resulted in a more pronounced radiosensitizing effect in HL-60 cells as compared to the inhibition of kinase ATM with the inhibitor KU55933. In contrast to KU55933, the VE-821 treatment prevented HL-60 cells from undergoing G2 cell cycle arrest. Taken together, we conclude that the ATR kinase inhibition offers a new possibility of radiosensitization of tumour cells lacking functional protein p53.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074695
- 003
- CZ-PrNML
- 005
- 20141009125341.0
- 007
- ta
- 008
- 141006s2013 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00411-013-0486-5 $2 doi
- 035 __
- $a (PubMed)23934411
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Vávrová, Jiřina $u Department of Radiobiology, Faculty of Health Sciences, University of Defence, Hradec Králové, Brno, Czech Republic, vavrova@pmfhk.cz.
- 245 10
- $a Inhibition of ATR kinase with the selective inhibitor VE-821 results in radiosensitization of cells of promyelocytic leukaemia (HL-60) / $c J. Vávrová, L. Zárybnická, E. Lukášová, M. Řezáčová, E. Novotná, Z. Sinkorová, A. Tichý, J. Pejchal, K. Durišová,
- 520 9_
- $a We compared the effects of inhibitors of kinases ATM (KU55933) and ATR (VE-821) (incubated for 30 min before irradiation) on the radiosensitization of human promyelocyte leukaemia cells (HL-60), lacking functional protein p53. VE-821 reduces phosphorylation of check-point kinase 1 at serine 345, and KU55933 reduces phosphorylation of check-point kinase 2 on threonine 68 as assayed 4 h after irradiation by the dose of 6 Gy. Within 24 h after gamma-irradiation with a dose of 3 Gy, the cells accumulated in the G2 phase (67 %) and the number of cells in S phase decreased. KU55933 (10 μM) did not affect the accumulation of cells in G2 phase and did not affect the decrease in the number of cells in S phase after irradiation. VE-821 (2 and 10 μM) reduced the number of irradiated cells in the G2 phase to the level of non-irradiated cells and increased the number of irradiated cells in S phase, compared to irradiated cells not treated with inhibitors. In the 144 h interval after irradiation with 3 Gy, there was a considerable induction of apoptosis in the VE-821 group (10 μM). The repair of the radiation damage, as observed 72 h after irradiation, was more rapid in the group exposed solely to irradiation and in the group treated with KU55933 (80 and 77 % of cells, respectively, were free of DSBs), whereas in the group incubated with 10 μM VE-821, there were only 61 % of cells free of DSBs. The inhibition of kinase ATR with its specific inhibitor VE-821 resulted in a more pronounced radiosensitizing effect in HL-60 cells as compared to the inhibition of kinase ATM with the inhibitor KU55933. In contrast to KU55933, the VE-821 treatment prevented HL-60 cells from undergoing G2 cell cycle arrest. Taken together, we conclude that the ATR kinase inhibition offers a new possibility of radiosensitization of tumour cells lacking functional protein p53.
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a ATM protein $x antagonisté a inhibitory $7 D064007
- 650 _2
- $a oprava DNA $x účinky léků $7 D004260
- 650 _2
- $a kontrolní body fáze G2 buněčného cyklu $x účinky léků $7 D059565
- 650 _2
- $a HL-60 buňky $7 D018922
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a akutní promyelocytární leukemie $x patologie $7 D015473
- 650 _2
- $a morfoliny $x farmakologie $7 D009025
- 650 _2
- $a inhibitory proteinkinas $x farmakologie $7 D047428
- 650 _2
- $a pyraziny $x farmakologie $7 D011719
- 650 _2
- $a pyrony $x farmakologie $7 D011753
- 650 _2
- $a tolerance záření $x účinky léků $7 D011836
- 650 _2
- $a sulfony $x farmakologie $7 D013450
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zárybnická, Lenka
- 700 1_
- $a Lukášová, Emilie
- 700 1_
- $a Řezáčová, Martina
- 700 1_
- $a Novotná, Eva
- 700 1_
- $a Sinkorová, Zuzana
- 700 1_
- $a Tichý, Aleš
- 700 1_
- $a Pejchal, Jaroslav
- 700 1_
- $a Durišová, Kamila
- 773 0_
- $w MED00004025 $t Radiation and environmental biophysics $x 1432-2099 $g Roč. 52, č. 4 (2013), s. 471-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23934411 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20141009125730 $b ABA008
- 999 __
- $a ok $b bmc $g 1042578 $s 873607
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 52 $c 4 $d 471-9 $i 1432-2099 $m Radiation and environmental biophysics $n Radiat Environ Biophys $x MED00004025
- LZP __
- $a Pubmed-20141006